ixazomib,daratumumab
takeda,janssen
['mmsm']
congress #asco22 | cyrille touzeau presents the updated results of the i-dara trial (without dex), a study designed for elderly frail patients with relapsed #myeloma. the ifm is also evaluating dara+len (no dex) in newly diagnosed patients #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma